Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Vanderbilt Team's Discovery Offers New Insight on Lung Cancer Risk


 

Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic "signature" from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.

Their findings, reported recently in the journal JCI Insight, are based on the observation that otherwise normal-looking cells in the epithelial lining of the lungs of heavy smokers and others at high risk for lung cancer undergo the same kind of "metabolic reprogramming" as do cancer cells.

To produce the extra lipids, nucleotides and amino acids they need to proliferate rapidly, cancer cells have to consume a lot of fuel, namely glucose. They essentially reverse the normal glucose-production cycle and "reprogram" their metabolism to increase uptake of glucose as well as glutamine, another quick-energy fuel.

The researchers discovered that normal cells in the lungs of heavy smokers do the same thing. The next step is to confirm that metabolic reprogramming is a "prerequisite for uncontrolled growth," said Jamshedur Rahman, PhD, research assistant professor of Medicine.

If so, metabolic reprogramming "would be a biomarker for risk," as well as an avenue for prevention, by targeting enzymes in metabolic pathways that lead to cancer, said senior author Pierre Massion, MD, Cornelius Vanderbilt Professor of Medicine and Cancer Biology.

"We're far from that target," said Massion, who directs the Cancer Early Detection and Prevention Initiative in the Vanderbilt-Ingram Cancer Center (VICC). "But this is a really exciting time for us."

Massion said the research could not have been done without major support from the National Cancer Institute (grant number CA152662) or the contributions of scientists across the University, including the paper's first authors, Rahman and research fellow Xiangming Ji, PhD.

Daniel Liebler, PhD, Ingram Professor of Cancer Research and director of the Jim Ayers Institute for Precancer Detection and Diagnosis at VICC, helped determine the "proteome," the unique set of proteins expressed in the lungs of cancer patients and those at high-risk for developing the disease.

Jamey Young, PhD, associate professor of Chemical and Biomolecular Engineering, developed software that enabled the researchers to track how glutamine was being used by epithelial cells.

Despite decades of attempts to thwart it, lung cancer remains the No. 1 cancer killer in the world, said Massion, who chairs the Lung Cancer Cooperative Group in the Early Detection Research Network, part of the National Cancer Institute.

"It's hard to stop a train that's going 200 miles an hour," he said. "We want to prevent this from gaining speed and, if possible, to ever get on the track."

 
Share:

Related Articles:


Recent Articles

April 12 Proclaimed Dr. Matthew Walker, Sr. Day

Mayor David Briley Presented Recognition at Event on April 12 at Meharry Medical College

Read More

Building on BUILD Health

In a new report from the de Beaumont Foundation, health system executives weigh in on working outside their facilities' four walls to impact community health

Read More

Addressing Physician Burnout

In recognition that physician burnout is increasing, the AMA and other companies and organizations have begun tackling the critical issue from a variety of vantage points

Read More

Study of Mucus May Help Guide Sinusitis Treatment

By April, nearly one-third of the U.S. is already experiencing high pollen levels while the weather and temperatures continue to fluctuate, aggravating sinus symptoms.

Read More

Tennessee Department Of Health Warns Of Phone Scam Attempt

Local and Out-of-State Residents May be Targeted

Read More

Senator Alexander Pushes for Better Data and Transparency of the Federal 340B Drug Pricing Program

Today, United States Senator Lamar Alexander (R-Tenn.) - chairman of the Senate's health committee - pushed for better data and transparency of the federal 340B Drug Pricing Program to ensure it's fulfilling its purpose to help hospitals care for low-income patients.

Read More

Blackburn Introduces Bipartisan Addiction & Recovery Act

Blackburn Introduces Bipartisan Comprehensive Addiction and Recovery Act 2.0 to Combat Opioid Epidemic

Read More

All In: Conversations on Health in Nashville

Is a person's zip code more important than their genetic code? Data suggests investing in social care could have a significant impact on healthcare.

Read More

Cumberland Pharmaceuticals Launches Oncology Division

Nashville-based Cumberland Pharmaceuticals has announced expansion into oncology support with the launch of a new corporate division.

Read More

Caring for Generations

Primary care provider Lorraine Charles, MD, has a passion for caring for the underserved in Nashville and beyond.

Read More

Email Print
 
 

 

 


Tags:
Jamshedur Rahman, Jim Ayers Institute for Precancer Detection and Diagnosis at VICC, lung cancer risk, Pierre Massion, Vanderbilt University
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: